Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 16 , ISSUE S3 ( December, 2024 ) > List of Articles

RESEARCH ARTICLE

Impact of Telephonic Reminders on Compliance with Iron–Folic Acid Supplementation among Pregnant Women at a Tertiary Care Institute in Ahmedabad, Gujarat: A Quasi-experimental Study

Monika Upadhyay, Venu Shah, Mohit Shah, Shanya Agrawal

Keywords : Anemia, Compliance, Iron–Folic acid supplementation, Pregnant women, Telephonic reminder

Citation Information :

DOI: 10.5005/jp-journals-10006-2566

License: CC BY-NC 4.0

Published Online: 03-02-2025

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Background: In India, around half of the pregnant women are suffering from anemia. Despite increasing coverage of iron–folic acid (IFA) supplementation, regular intake of IFA supplements is lacking among antenatal women in India. Various reasons behind poor compliance are forgetfulness, fear of side effects of IFA tablets, insufficient counseling, etc. Objective: The primary objective was to evaluate the difference in the compliance to IFA supplementation among the study group (who have received the telephonic reminder) with the control group (who did not receive the telephonic reminder). Secondary objectives were to assess the predictors of compliance to IFA supplementation and reasons behind poor compliance to IFA tablets among study participants. Materials and methods: A quasi-experimental study was conducted among a total of 300 pregnant women. Out of them, 150 were from the study group, who received the telephonic reminder on weekly basis, while 150 pregnant women belonged to the control group, who did not receive the telephonic reminder. Pregnant women were inquired about the number of tablets remaining with them for evaluating the compliance. Compliance was considered good if a woman has consumed all the prescribed doses of the IFA tablet. At the time of follow-up visits, women with poor compliance were asked for reasons behind the same. Results: The mean age of participants was 26.9 ± 4.3 years and 26.9 ± 3.6 years in the study group and control group, respectively. Among the study, 64 (42.7%) and 70 (46.7%) participants were primigravida in the study and control groups, respectively. At the end of 2 months, good compliance to IFA supplementation was 53% and 30% in the study and control groups, respectively. The difference was significant statistical (p-value < 0.001). The most common reasons behind poor compliance among the control group were forgetfulness (31.9%) and side effects of the treatment (28.6%). Conclusion: Compliance was significantly higher among the study group, who received weekly telephonic reminders. The factors determining the compliance were knowledge about complication of anemia, number of iron tablets prescribed, social class, and the type of family.


PDF Share
  1. Prevalence of anaemia in women aged 15-49, by pregnancy status (%), Available from https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4552. Accessed on 19 May 2023.
  2. Kapil U, Singh Bhadoria A. National iron-plus initiative guidelines for control of iron deficiency anaemia in India, 2013. Natl Med J India 2014;27:27–29. PMID: 25403123.
  3. Joe W, Patel R, Alambusha R, et al. Coverage of iron and folic acid supplementation in India: Progress under the anemiamukt Bharat strategy 2017-20. Health Policy Plan 2022;37(5):597–606. DOI: 10.1093/heapol/czac015.
  4. Anemia in prgnant women. NHFS 5. Available from: https://factly.in/data-nfhs-5-findings-reveal-increase-in-anaemia-prevalence-in-children-women-across-most-states/#:~:text=The%20increase%20in%20anaemia%20among,women%20by%205%20percentage%20points. Accessed on 19 May 2023.
  5. Khanam A, Vohra K, Achary TMG, et al. A Systematic review of factors affecting compliance toward oral iron-folic acid supplementation among pregnant women in India. Indian J Comm Health 2022;34(4):456–463. DOI:10.47203/IJCH.2022.v34i04.002.
  6. Mithra P, Unnikrishnan B, Rekha T, et al. Compliance with iron-folic acid (IFA) therapy among pregnant women in an urban area of south India. Afr Health Sci 2014;14:255–260. DOI: 10.4314/ahs.v13i4.3.
  7. Sontakke P, Dwidmuthe KS, Kawathalkar A, et al. Effect of mobile phone call reminders with standard therapy versus standard therapy alone on compliance with iron supplementation in antenatal women with iron deficiency anemia: A randomized controlled trial. Cureus 2022;14(9):e29501. DOI 10.7759/cureus.29501.
  8. Javalkar SR, Shalini H, Davalagi SB, et al. Socio economic status assessment in India: History and updates for 2024. Int J Community Med Public Health 2024;11:1369–1377. DOI: 10.18203/2394–6040.ijcmph20240648.
  9. WHO: Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. eng.pdf 2011. Accessed on 19 May 2023.
  10. Khorshid MR, Afshari P, Abedi P. The effect of SMS messaging on the compliance with iron supplementation among pregnant women in Iran: A randomized controlled trial. J Telemed Telecare 2014;20(4):201–206. DOI: 10.1177/1357633X14533895.
  11. Kamau M, Kimani S, Mirie W. Counselling and knowledge on iron and folic acid supplementation (IFAS) among pregnant women in Kiambu County, Kenya: A cross-sectional study. AAS Open Res 2019;1:21. DOI: 10.12688/aasopenres.12891.3.
  12. Ahmed S, Islam TT, Huda FA, et al. Decision-making process in seeking antenatal care: A cohort study in a poor urban and a typical rural area in Bangladesh. J Glob Health 2024;14:04097. DOI: 10.7189/jogh.14.04097.
  13. Khatri RB, Karkee R, Durham J, et al. Universal coverage of the first antenatal care visit but poor continuity of care across the maternal and newborn health continuum among Nepalese women: Analysis of levels and correlates. Global Health 2021;17:141. DOI: 10.1186/s12992-021-00791-4.
  14. Lavanya P, Jayalakshmy R, Rajaa S, et al. Adherence to iron and folic acid supplementation among antenatal mothers attending a tertiary care center, Puducherry: A mixed-methods study. J Family Med Prim Care 2020;9(10):5205–5211. DOI: 10.4103/jfmpc.jfmpc_721_20.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.